IPF Clinical Trials

31 recruitingLast updated: June 18, 2026

There are 31 actively recruiting ipf clinical trials across 25 countries. Studies span Phase 2, Not Applicable, Phase 1, Phase 3. Top locations include Birmingham, Alabama, United States, Winston-Salem, North Carolina, United States, El Paso, Texas, United States. Updated daily from ClinicalTrials.gov.


IPF Trials at a Glance

31 actively recruiting trials for ipf are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Phase 2 with 11 trials, with the heaviest enrollment activity in Birmingham, Winston-Salem, and El Paso. Lead sponsors running ipf studies include Avalyn Pharma Inc., Hospital de Granollers, and Saglik Bilimleri Universitesi.

Browse ipf trials by phase

Treatments under study

About IPF Clinical Trials

Looking for clinical trials for IPF? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new IPF trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about IPF clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 2

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
Rein Therapeutics120 enrolled16 locationsNCT06968845
Recruiting
Phase 2

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
Dragonboat Biopharmaceutical Company Limited96 enrolled1 locationNCT07447102
Recruiting

P4O2 ILD Extension

Interstitial Lung DiseasePulmonary FibrosisIPF+7 more
Amsterdam UMC, location VUmc450 enrolled1 locationNCT06644144
Recruiting
Phase 1

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
Mannkind Corporation24 enrolled9 locationsNCT07344558
Recruiting
Phase 2

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.340 enrolled52 locationsNCT06951217
Recruiting
Phase 3

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Idiopathic Pulmonary Fibrosis (IPF)
Sunshine Lake Pharma Co., Ltd.472 enrolled1 locationNCT07082842
Recruiting
Not Applicable

Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Fibrotic interstitial lung diseaseInterstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers92 enrolled1 locationNCT07482917
Recruiting
Not Applicable

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Progressive Pulmonary FibrosisFibrotic interstitial lung diseaseInterstitial Lung Disease (ILD)+2 more
Hospital de Granollers152 enrolled1 locationNCT07486206
Recruiting
Phase 2

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.160 enrolled3 locationsNCT07194382
Recruiting
Phase 3

A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)
Beijing Tide Pharmaceutical Co., Ltd508 enrolled1 locationNCT07464912
Recruiting
Phase 2

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

Idiopathic Pulmonary Fibrosis (IPF)
Vicore Pharma AB360 enrolled117 locationsNCT06588686
Recruiting
Not Applicable

Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)Fibrotic Interstitial Lungs Diseases
Katerina M. Antoniou100 enrolled1 locationNCT07466420
Recruiting
Phase 1

A Phase Ia Clinical Trial of HW241045

Healthy VolunteersIPF
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.56 enrolled1 locationNCT07448194
Recruiting
Phase 2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
Shanghai Synvida Biotechnology Co.,Ltd.48 enrolled12 locationsNCT07121413
Recruiting

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Royal Brompton & Harefield NHS Foundation Trust30 enrolled1 locationNCT07332117
Recruiting
Phase 1

Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

IPF
Agomab Spain S.L.145 enrolled1 locationNCT06181370
Recruiting
Phase 2

Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis

IPF and PPF
Guangdong Hengrui Pharmaceutical Co., Ltd270 enrolled1 locationNCT07192939
Recruiting
Not Applicable

Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis

IPF
Istanbul Medipol University Hospital44 enrolled1 locationNCT05190211
Recruiting
Phase 2

SB17170 Phase 2 Trial in IPF Patients

Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)IPF
SPARK Biopharma30 enrolled5 locationsNCT06747923
Recruiting

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

SmokingSmoking CessationChronic Obstructive Pulmonary Disease (COPD)+3 more
Weill Medical College of Cornell University2,000 enrolled1 locationNCT01776398